Healthcare >> Analyst Interviews >> December 6, 1999

Biotherapeutics Stocks : Michael G. King Jr. – Robertson Stephens

MICHAEL G. KING, JR. is a Managing Director and Senior Biotechnology Analyst at Robertson Stephens. He focuses on the genomics sector. Prior to joining Robertson Stephens he was a Senior Biotechnology Analyst at Vector Securities International and served as Vice President of Research, Biotechnology, with Dillon, Read & Co., Inc. Mr. King also has been a Senior Vice President of Sales at Alex. Brown and Sons. In 2001, he ranked fourth for his stock-picking accuracy in The Wall Street Journal's annual 'Best on the Street' survey. In 2000, Mr. King was given the Institutional Investor Home Run Hitter award for his coverage of OSI Pharmaceuticals. He holds a BBA degree from Baruch College. Profile
TWST: Tell me about the sectors you cover.

Mr. King: We cover a variety of different industries, including

traditional biotherapeutics companies as well as companies in the tools

space. These